<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <cboCostEstimates />
    <notes />
    <updateDate>2019-10-18T16:07:39Z</updateDate>
    <sponsors>
      <item>
        <bioguideId>V000130</bioguideId>
        <lastName>Vargas</lastName>
        <byRequestType />
        <fullName>Rep. Vargas, Juan [D-CA-51]</fullName>
        <middleName />
        <party>D</party>
        <identifiers>
          <bioguideId>V000130</bioguideId>
          <lisID>2112</lisID>
          <gpoId />
        </identifiers>
        <district>51</district>
        <firstName>Juan</firstName>
        <state>CA</state>
      </item>
    </sponsors>
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <date>2018-09-13T14:05:25Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <type>Standing</type>
          <systemCode>hsif00</systemCode>
          <chamber>House</chamber>
          <name>Energy and Commerce Committee</name>
          <subcommittees />
        </item>
      </billCommittees>
    </committees>
    <originChamber>House</originChamber>
    <cosponsors>
      <item>
        <firstName>Thomas</firstName>
        <sponsorshipDate>2018-09-13</sponsorshipDate>
        <lastName>Rooney</lastName>
        <fullName>Rep. Rooney, Thomas J. [R-FL-17]</fullName>
        <identifiers>
          <gpoId>7888</gpoId>
          <bioguideId>R000583</bioguideId>
          <lisID>1916</lisID>
        </identifiers>
        <district>17</district>
        <sponsorshipWithdrawnDate />
        <bioguideId>R000583</bioguideId>
        <state>FL</state>
        <party>R</party>
        <middleName>J.</middleName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <firstName>Scott</firstName>
        <sponsorshipDate>2018-09-13</sponsorshipDate>
        <lastName>Peters</lastName>
        <fullName>Rep. Peters, Scott H. [D-CA-52]</fullName>
        <identifiers>
          <bioguideId>P000608</bioguideId>
          <lisID>2113</lisID>
          <gpoId />
        </identifiers>
        <district>52</district>
        <sponsorshipWithdrawnDate />
        <bioguideId>P000608</bioguideId>
        <state>CA</state>
        <party>D</party>
        <middleName>H.</middleName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <summaries>
      <billSummaries>
        <item>
          <updateDate>2018-09-13T04:00:00Z</updateDate>
          <actionDesc>Introduced in House</actionDesc>
          <lastSummaryUpdateDate>2019-08-20T20:32:00Z</lastSummaryUpdateDate>
          <versionCode>00</versionCode>
          <text><![CDATA[<p><b>Rare Disease Fund Act of 2018 or the RaD Fund Act of 2018</b></p> <p>This bill requires the Department of the Treasury to organize the Rare Disease Therapeutics Corporation to purchase rights to, fund the development of, and sell ownership interests in drugs, biological products, and medical devices for rare diseases.</p>]]></text>
          <name>Introduced in House</name>
          <actionDate>2018-09-13</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <billType>HR</billType>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <laws />
    <title>RaD Fund Act of 2018</title>
    <latestAction>
      <links />
      <actionDate>2018-09-13</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr6801ih/xml/BILLS-115hr6801ih.xml</url>
          </item>
        </formats>
        <date>2018-09-13T04:00:00Z</date>
      </item>
    </textVersions>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
      <actionTypeCounts>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
        <billReferrals>1</billReferrals>
      </actionTypeCounts>
      <item>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <type>IntroReferral</type>
        <links />
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <actionDate>2018-09-13</actionDate>
      </item>
      <item>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committee />
        <type>IntroReferral</type>
        <links />
        <text>Introduced in House</text>
        <actionDate>2018-09-13</actionDate>
      </item>
      <item>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committee />
        <type>IntroReferral</type>
        <links />
        <text>Introduced in House</text>
        <actionDate>2018-09-13</actionDate>
      </item>
    </actions>
    <congress>115</congress>
    <recordedVotes />
    <version>1.0.0</version>
    <subjects>
      <billSubjects>
        <legislativeSubjects />
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <titles>
      <item>
        <chamberCode />
        <title>To establish a Rare Disease Therapeutics Corporation to encourage the development of high-risk, high-return therapies for rare diseases, and for other purposes.</title>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>Rare Disease Fund Act of 2018</title>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>RaD Fund Act of 2018</title>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>RaD Fund Act of 2018</title>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>RaD Fund Act of 2018</title>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>Rare Disease Fund Act of 2018</title>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <createDate>2018-09-14T07:10:50Z</createDate>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 164, Number 153 (Thursday, September 13, 2018)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. VARGAS:H R. 6801.Congress has the power to enact this legislation pursuantto the following:(1) to lay and collect taxes, duties, imposts and excises,to pay the debts and provide for the common defense andgeneral welfare of the United States; but all duties, impostsand excises shall be uniform throughout the United States, asenumerated in Article 1, Section 8, Clause 1 of the U.S.Constitution;(2) To borrow money on the credit of the United States, asenumerated in Article 1, Section 8, Clause 2 of the U.S.Constitution;(3) To regulate commerce with foreign nations, and amongthe several states, and with the Indian tribes, as enumeratedin Article 1, Section 8, Clause 3 of the U.S. Constitution;(4) To promote the progress of science and useful arts, bysecuring for limited times to authors and inventors theexclusive right to their respective writings and discoveriesas enumerated in Article 1, Section 8, Clause 8 of the U.S.Constitution;(5) to make all laws necessary and proper for executingpowers vested by the Constitution in the Government of theUnited States, as enumerated in Article I, Section 8, Clause18 of the United States Constitution.[Page H8726]</pre>]]></constitutionalAuthorityStatementText>
    <introducedDate>2018-09-13</introducedDate>
    <committeeReports />
    <billNumber>6801</billNumber>
    <relatedBills />
    <calendarNumbers />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

